Concourse Financial Group Securities, Inc. Calliditas Therapeutics Ab Transaction History
Concourse Financial Group Securities, Inc.
- $1.64 Billion
- Q3 2024
Shares
18 transactions
Others Institutions Holding CALT
# of Institutions
4Shares Held
4.17KCall Options Held
0Put Options Held
0About Calliditas Therapeutics AB
- Ticker CALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,624,800
- Market Cap $1.06B
- Description
- Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...